Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein
- 12 August 2003
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 66 (6) , 965-976
- https://doi.org/10.1016/s0006-2952(03)00414-3
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC‐3International Journal of Cancer, 2002
- Soy isoflavonoids and cancer — metabolism at the target siteMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2001
- p53 is involved in tumor necrosis factor-α-induced apoptosis in the human prostatic carcinoma cell line LNCaPOncogene, 2000
- The Protein Data BankNucleic Acids Research, 2000
- Genistein‐induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cellsNutrition and Cancer, 1998
- Structure of 20S proteasome from yeast at 2.4Å resolutionNature, 1997
- Proteasome-Dependent Regulation of p21WAF1/CIP1ExpressionBiochemical and Biophysical Research Communications, 1996
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- The Role of Soy Products in Reducing Risk of CancerJNCI Journal of the National Cancer Institute, 1991
- Effect of genistein on topoisomerase activity and on the growth of [VAL 12]Ha-ras-transformed NIH 3T3 cellsBiochemical and Biophysical Research Communications, 1988